The Centers for Medicare and Medicaid Services have expanded the set of telehealth services that are fully reimbursable. Remote follow-ups and monitoring can be billed up to four times per month per patient.
Telehealth consultations, often just as beneficial to patients as office visits, demand less time and expense from a doctor's practice.
In light of the pandemic, telehealth affords patients and doctors a means to avoid nonessential travel and social interaction.
How Does DiyaMD Play a Role?
Current telehealth technologies — except for DiyaMD — are outdated. DiyaMD eliminates their inherent shortcomings with capabilities unavailable elsewhere. A few examples:
Follow-ups: One survey reveals that only 35% of telehealth patients received a follow-up. DiyaMD automatically generates follow-up alerts as commanded — e.g., "in three days," or "in seven days," or "in thirty days." It also can schedule follow-ups based on other factors — e.g., a patient's disease, medicines, age, etc. — a helpful feature when treating the chronically or seriously ill. In this way, no opportunity for reimbursable service is missed.
Vital signs, medicines: No office visit is required when DiyaMD is used to view a patient's latest vital signs and current medicines. Doctors know that obtaining vital signs over a video call is difficult and time consuming. Worse yet, the readings often are unreliable.
Efficiency and high throughput: The doctor can call the patient when necessary, by voice only or voice/video, right from the DiyaMD software, where it is tracked as a billable service.
Trendlines: DiyaMD makes these always available to the doctor. When reviewed, even by phone, the review activity is tracked as a billable service.
DiyaMD and its complementary patient-facing software, myDiya, comprise a novel platform that focuses on high efficiency, high throughput, and billable patient-care services. It has unique capabilities for doctors, patients, and caregivers. We have already written to you about some of these, and will write to you about more.
